Oral Steroids for Acute Otitis Media
Oral steroids are NOT indicated for the treatment of acute otitis media in children or adults. The evidence consistently shows no significant benefit, and current guidelines do not recommend their use.
Evidence from Guidelines
The American Academy of Otolaryngology-Head and Neck Surgery 2017 guideline explicitly addresses systemic steroids for AOM. A 2013 systematic review identified only one RCT (from 2003) comparing intramuscular ceftriaxone combined with 5 days of oral prednisolone versus placebo in children with AOM, which found no significant benefit of systemic steroids 1. This represents the highest-quality guideline evidence available, and it clearly does not support steroid use.
The 2013 AAP/AAFP guideline for AOM management makes no mention of steroids as a treatment option, focusing instead on diagnostic criteria, observation strategies, and antibiotic selection 2. This omission is telling—if steroids were beneficial, they would be included in the treatment algorithm.
Supporting Research Evidence
The most comprehensive and recent evidence comes from a 2018 Cochrane systematic review that included two studies with 252 children 3. The findings were:
- Pain outcomes: One study included pain but couldn't derive meaningful data on persistent pain at Days 5 and 14
- Symptom resolution: At Day 5,94% in the steroid group versus 89% in placebo showed improvement (RR 1.06,95% CI 0.97-1.16); at Day 14,91% versus 87% (RR 1.05,95% CI 0.95-1.17)
- Quality of evidence: Low to very low, meaning we cannot be certain of any effect
The Cochrane authors concluded: "The evidence for the effect of systemic corticosteroids on AOM is of low to very low quality, meaning the effect of systemic corticosteroids on important clinical outcomes in AOM remains uncertain" 3.
Contradictory Evidence Requiring Discussion
Two older studies suggested potential benefit, but they have critical limitations:
- A 2003 RCT (n=179) found one treatment group had more favorable outcomes, but the effect size was small and the study was at unclear-to-high risk of bias 4
- A 1999 study showed benefit for AOM with discharge through tympanostomy tubes specifically—a different clinical scenario than standard AOM 5
Importantly, the 2003 study also found that antihistamine use prolonged middle ear effusion duration (median 73 days versus 23-36 days), suggesting potential harm from anti-inflammatory adjuncts 4.
Clinical Bottom Line
When deciding whether to use oral steroids for AOM:
- Do NOT prescribe oral steroids as routine treatment for AOM in children or adults
- Follow established guidelines: Use amoxicillin as first-line antibiotic when treatment is indicated 2
- Focus on appropriate antibiotic selection and observation strategies based on age, severity, and laterality 2
- Reserve steroids for other indications: The evidence supports steroids for otitis media with effusion (OME) in specific contexts, but not for acute infection 1
Common Pitfalls to Avoid
- Don't confuse AOM with OME: Steroids may have a role in OME (chronic effusion without acute infection), but not in AOM 1
- Don't extrapolate from tympanostomy tube studies: The 1999 study showing benefit was specifically for discharge through tubes, not intact tympanic membranes 5
- Avoid polypharmacy without evidence: Adding steroids or antihistamines to antibiotics increases medication burden without proven benefit and may prolong effusion 4
The evidence base is insufficient to support oral steroid use in AOM, and no high-quality recent studies have emerged to change this recommendation.